Daniel Metzen Selected Research

Daniel Metzen Research Topics

2	Hemorrhage 01/2023 - 01/2021
2	Non-ST Elevated Myocardial Infarction 01/2022 - 01/2020
1	Cardiogenic Shock 12/2023
1	Atrial Fibrillation 01/2023
1	Ischemia 01/2023
1	Infarction (Infarctions) 01/2023
1	ST Elevation Myocardial Infarction 01/2023
1	Starvation 01/2022
1	Transient Ischemic Attack 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Stroke (Strokes) 11/2021
1	Myocardial Infarction 11/2021
1	Diabetes Mellitus 01/2021
1	Autistic Disorder (Autism) 06/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020

2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 12/2023
1	Vitamin K FDA Link 01/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2023
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2023
1	RivaroxabanIBA 01/2023
1	apixabanIBA 01/2023
1	CarbonIBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	Dipyrone (Metamizole)IBA 11/2021
1	NexusIBA 06/2020

1	Percutaneous Coronary Intervention 01/2021
1	Secondary Prevention 01/2020